Nalfurafine
Nalfurafine is a pharmaceutical drug that acts as a kappa-opioid receptor agonist. It is primarily used in the treatment of pruritus (itching) associated with chronic kidney disease and liver disease. Nalfurafine is notable for its unique pharmacological profile, which allows it to alleviate itching without the typical side effects associated with other opioid medications, such as sedation and respiratory depression.
Pharmacology[edit]
Nalfurafine works by selectively activating the kappa-opioid receptors in the central and peripheral nervous systems. Unlike other opioids that primarily target the mu-opioid receptor, nalfurafine's selective action on kappa receptors helps to reduce the sensation of itching without causing significant euphoria or addiction potential. This makes it a valuable option for patients who require long-term management of pruritus.
Medical Uses[edit]
Nalfurafine is approved for use in several countries, including Japan and the United States, for the treatment of pruritus in patients undergoing hemodialysis or those with chronic liver disease. It is often prescribed when other treatments, such as antihistamines and corticosteroids, are ineffective.
Side Effects[edit]
Common side effects of nalfurafine include:
Serious side effects are rare but may include:
Mechanism of Action[edit]
Nalfurafine's mechanism of action involves the modulation of neurotransmitter release in the central nervous system. By binding to kappa-opioid receptors, it inhibits the release of substance P and other neuropeptides involved in the transmission of itch signals. This results in a reduction of the sensation of itching.
Development and Approval[edit]
Nalfurafine was developed by the Japanese pharmaceutical company Toray Industries. It was first approved for use in Japan in 2009 under the brand name Remitch and has since been approved in other countries for similar indications.
See Also[edit]
References[edit]
External Links[edit]
-
| Nalfurafine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
